Abstract
Purpose
Intensive proliferation and a high degree of migration and invasion are characteristic features of malignant glioblastomas, associated with a poor prognosis. Phosphatidylinositol-3-kinase (Pi3-K) and protein kinase C (PKC) are two phosphorylated proteins involved in glioblastoma cell progression. Phosphorylated focal adhesion protein kinase (FAK) has also been reported to be involved in tumour progression. In a recent study, we demonstrated a correlation between phosphorylated FAK, proliferation rate and 99mTc-(V)-dimercaptosuccinate [(V)-DMSA] uptake. We hypothesised that 99mTc-(V)-DMSA could be a potential imaging agent to evaluate glioblastoma aggressiveness. The aim of the present study was to assess the relationship between 99mTc-(V)-DMSA incorporation rate and modulation of Pi3-K and PKC activity.
Methods
Proliferation, migration and invasion capacities in the presence of protein kinase modulators—staurosporine (PKC inhibitor), 4-phorbol 12-myristate 13-acetate (PMA; PKC activator) and LY294002 (Pi3-K inhibitor)—were correlated with 99mTc-(V)-DMSA cell accumulation in an in vitro model of several malignant glioma cells: G111 (grade II), U-87-MG (grade III) and G152 (grade IV).
Results
In all cell lines tested, LY294002 and staurosporine treatment inhibited cell proliferation, migration and invasion. In contrast, treatment with PMA stimulated tumour aggressiveness. 99mTc-(V)-DMSA uptake was strongly correlated with the % of cellular proliferation (r=0.8462) and the % of cellular migration (r=0.9081), and to a lesser extent with the % of cellular invasion (r=0.7761).
Conclusion
Our results clearly demonstrated that 99mTc-(V)-DMSA reflects Pi3-K and PKC activity and is correlated with tumour aggressiveness. 99mTc-(V)-DMSA could be a reliable in vivo marker providing additional information on the biological status of malignant glioblastoma.
Similar content being viewed by others
References
Lemke DM. Epidemiology, diagnosis, and treatment of patients with metastatic cancer and high-grade gliomas of the central nervous system. J Infus Nurs 2004;27:263–269
Basu S, Nair N, Awasare S, Tiwari BP, Asopa R, Nair C. 99Tcm(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications. Br J Radiol 2004;7:347–361
Atasever T, Gundogdu C, Vural G, Kapucu LO, Karalezli A, Unlu M. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers. Nuklearmedizin 1997;36:223–227
Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, et al. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade. J Nucl Med 1997;38:1741–1749
Hirano T, Otake H, Shibasaki T, Tamura M, Endo K. Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA. J Nucl Med 1997;38:20–26
Denoyer D, Perek N, Le Jeune N, Frere D, Dubois F. Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumor cell lines. Eur J Nucl Med Mol Imaging 2004;31:77–84
Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F. Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging 2005;32(7):820–827
Perez-Roger I, Ivorra C, Diez A, Cortes MJ, Poch E, Sanz-Gonzalez SM, et al. Inhibition of cellular proliferation by drug targeting of cyclin-dependent kinases. Curr Pharm Biotechnol 2000;1(1):107–116
Sridhar R, Hanson-Painton O, Cooper DR. Protein kinases as therapeutic targets. Pharm Res 2000;17(11):1345–1353
Brader S, Eccles SA. Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 2004;90(1):2–8
Krasilnikov MA. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry 2000;65:59–67
Couldwell WT, Hinton DR, Law RE. Protein kinase C and growth regulation in malignant gliomas. Neurosurgery 1994;35(6):1184–1186
Musashi M, Ota S, Shiroshita N. The role of protein kinase C isoforms in cell proliferation and apoptosis. Int J Hematol 2000;72(1):12–19
Kakita A, Suzuki A, Nishiwaki K, Omo Y, Kotake M, Ariyoshi Y, et al. Stimulation of Na-dependent phosphate transport by platelet-derived growth factor in rat aortic smooth muscle cells. Atherosclerosis 2004;174:17–24
Yokoyama A, Hata N, Horiuchi K, Nasuda H, Saji H, Ohta H, et al. The design of a pentavalent 99mTc-dimercaptosuccinate complex as a tumor imaging agent. Int J Nucl Med Biol 1985;12:273–279
Zhang W, Law RE, Hinton DR, Couldwell WT. Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor. Cancer Lett 1997;25:120:31–38
Mohan DRK, Nagarathna R, Krishna M, Jagtap JC, Shastry P. Differential responses of staurosporine on protein kinase C activity and proliferation in two murine neuroblastoma cell lines. Cancer Lett 1999;139:137–143
Park MJ, Park IC, Hur JH, Rhee CH, Choe TB, Yi DH, et al. Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. Neurosci Lett 2000;290:201–204
Pollack IF, Randall MS, Kristofill MP, Kelly RH, Selker RG, Vertosick FT. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways. J Neurosurg 1990;73:98–105
Demuth T, Berens M. Molecular mechanisms of glioma cell migration and invasion. J Neuro-oncol 2004;70:217–228
Joy A, Beaudry C, Tran N, Ponce F, Holz D, Demuth T, et al. Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 2003;116:4409–4417
Nicholson KM, Quinn DM, Kellett GL, Warr JR. LY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells. Cancer Lett 2003;190:31–36
Ma AD, Metjian A, Bragrodia S, Taylor S, Abrams CS. Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase gamma, a Rac guanosine exchange factor, and Rac. Mol Cell Biol 1998;18:4744–4451
Kubiatowski T, Jang T, Lachyankar MB, Salmonsen R, Nabi RR, Quesenberry PJ. Association of increased phosphatidylinositol 3-kinase signalling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg 2001;95:379–380
Papantoniou V, Souvatzoglou M, Valotassiou V, Louvrou A, Ambela C, Koutsikos J, et al. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer. Breast Cancer Res 2004;6:R56–62
Papantoniou V, Tsiouris S. In vitro verification of the correlation of in vivo 99mTc-(V)DMSA uptake with cellular proliferation rate. Eur J Nucl Med Mol Imaging 2005;32(10):1240–1241
Acknowledgements
This work was supported by grants from Ligue National Contre le Cancer – Comité Départemental de la Loire. We thank Dr. A. Saul for revising the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Le Jeune, N., Perek, N. & Dubois, F. Influence of Pi3-K and PKC activity on 99mTc-(V)-DMSA uptake: correlation with tumour aggressiveness in an in vitro malignant glioblastoma cell line model. Eur J Nucl Med Mol Imaging 33, 1206–1213 (2006). https://doi.org/10.1007/s00259-006-0122-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-006-0122-6